1.Pathomechanisms of torsades de pointes.
Ding SHAOXIANG ; Qi GUORONG ; Liu PINFA
Chinese Journal of Cardiology 2015;43(8):670-672
2.Torsade de Pointes Induced by Long-Term Oral Amiodarone Therapy.
Jong Ho NAM ; Yoon Jung CHOI ; Min Kyu KANG ; Sung Yun JUNG ; Su Mi KIM ; Sang Hee LEE ; Dong Gu SHIN
Yeungnam University Journal of Medicine 2011;28(1):90-93
Although amiodarone is generally regarded as safe with a low incidence of associated arrhythmias, torsade de pointes (TdP) has been observed usually in the presence of predisposing factors. We report a case of amiodarone-induced TdP after long-term administration of a low dose of oral amiodarone in the absence of predisposing factors.
Amiodarone
;
Arrhythmias, Cardiac
;
Incidence
;
Torsades de Pointes
3.Magnesium Sulfate in the Treatment of Torsade De Pointes.
Cheol Whan LEE ; Jae Joong KIM ; Jae Kwan SONG ; Seong Wook PARK ; Seung Jung PARK ; Jong Koo LEE
Korean Circulation Journal 1994;24(4):617-623
No abstract available.
Magnesium Sulfate*
;
Magnesium*
;
Torsades de Pointes*
4.Torsades de pointes observed in the early postoperative period in a patient with long QT syndrome.
Min Soo KIM ; Seung Gyun NAM ; Yong Seon CHOI
Korean Journal of Anesthesiology 2013;64(1):89-90
No abstract available.
Humans
;
Long QT Syndrome
;
Postoperative Period
;
Torsades de Pointes
5.A Case of Torsades de Pointes Induced by Complete Atrioventricular Block and Hypokalemia.
Woo Jae KIM ; Jang Young KIM ; Hun Su JU ; Jung Kwon KIM ; Hyun Sook JUNG ; Byung Su YOO ; Seung Hwan LEE ; Jung Han YOON ; Kyung Hoon CHOE ; Sang Ha KIM
Korean Circulation Journal 2004;34(2):220-223
Torsades de pointes (TdP) is a rare complication of a complete atrioventricular block with QT prolongation. Additional risk factors, such as hypokalemia, may increase the risk of TdP during atrioventricular (AV) block. We experienced a case of TdP, caused by a complete heart block and hypokalemia, which was successfully treated by implanting a permanent pacemaker and correction of the electrolyte imbalance.
Atrioventricular Block*
;
Heart Block
;
Hypokalemia*
;
Risk Factors
;
Torsades de Pointes*
8.Torsades de Pointes After Combined Treatment of Terfenadine and Ketoconazole.
Sang Joon PARK ; Ki Hyun KIM ; June Soo KIM ; Jae Choon RYU ; Shin Bae JOO ; Hyeon Cheol GWON ; Seung Woo PARK ; Duk Kyung KIM ; Sang Hoon LEE ; Kyung Pyo HONG ; Jeong Euy PARK ; Won Ro LEE
Korean Journal of Medicine 1998;54(1):124-130
Terfenadine is widely used because of nonsedating effect. But It could rarely provoke a potentially lethal ventricular tachyarrhythmia. Recently, we experienced two cases of torsades de pointes(TDP) of occurred after combined use of terfenadine and ketoconazole in usual dose. In one case, 31-yr-old female presented palpitation and recurrent syncope of sudden onset after ingestion of terfenadine 60mg and ketoconzole 200mg 5 times. On attack, ECG showed a polymorphic ventricular tachycardia, and after attack, showed prolongation of QT interval and TU wave changes. Her laboratory findings were not contributory. TDP was controlled with MgSO4 and isoproterenol infusion. Then, QT interval was normalized and no further episode occurred. In the other case, 32-yr-old female presented palpitation and recurrent syncope of sudden onset after ingestion of terfenadine 60mg and ketoconzole 200mg 5 times. ECG showed prolongation of QT interval and TU wave changes. Her laboratory findings were not contributory. TDP was controlled with MgSO4 and isoproterenol infusion. Then, QT interval was normalized and no further episode occurred.
Eating
;
Electrocardiography
;
Female
;
Humans
;
Isoproterenol
;
Ketoconazole*
;
Syncope
;
Tachycardia
;
Tachycardia, Ventricular
;
Terfenadine*
;
Torsades de Pointes*
9.Levofloxacin and Torsades de Pointes.
Se Ah KWON ; Cheol Hong KIM ; Won Jun SONG ; Ja Kyung KOO ; Soon Jae LEE ; Ji Young PARK ; In Gyu HYUN ; Jang Hyu KO ; Hyun Soo KIM
Tuberculosis and Respiratory Diseases 2010;69(6):474-479
Torsades de pointes associated with a prolonged QT interval is a life-threatening arrhythmia, which may be induced by any of the following: drugs, electrolyte imbalances, severe bradycardia and intracranial hemorrhage. Torsades de pointes is characterized by beat-to-beat variations in the QRS complexes in any ECG leads with rates of 200~250 per minute. Fluoroquinolones are widely used and well tolerated antibacterial agents. However, prolongation of the QT interval leads rarely to Torsades de pointes as a significant adverse effect. So, it should be used with caution in high-risk patients for developing Torsades de pointes. We report one case of 67-year old man with contact burns who experienced Torsades de pointes, which probably resulted from the use of levofloxacin, and no further episode occurred after its withdrawal.
Anti-Bacterial Agents
;
Arrhythmias, Cardiac
;
Bradycardia
;
Burns
;
Electrocardiography
;
Fluoroquinolones
;
Humans
;
Intracranial Hemorrhages
;
Ofloxacin
;
Torsades de Pointes
10.A Case of Phenothiazine-induced Torsades de Pointes.
Seon Hee CHOI ; Man Jong CHO ; Moo Jung PARK ; Jeong Pyo HONG ; Sang Ho LEE ; Won Bo SHIM
Korean Journal of Medicine 1997;52(1):137-142
Torsades de pointes (TdP) is a form of polymorphic ventricular tachycardia associated with a prolonged QT interval or increased U wave. It may occur either in the congenital(idiopathic) form or in the aquired form. Although aquired TdP could be found in many clinical settings such as various drugs, bradycardia, or electrolyte imbalance, it is most commonly induced by drugs. The underlying mechanism is though to be the triggered activity arising as a consequence of early afterdepolarization. Phenothiazine has many derivatives that can lead to occur the cardiovascular events including hypotension, syncope, tachycardia and various ECG changes. Chloropromazine is a propylamine derivative of phenothiazine. We report a case of TdP occurred after chloropromazine usual dosage.
Bradycardia
;
Chlorpromazine
;
Electrocardiography
;
Hypotension
;
Syncope
;
Tachycardia
;
Tachycardia, Ventricular
;
Torsades de Pointes*